These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 27535740)
21. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
22. Wilms tumor protein 1 (WT1)-- not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinoma. Taube ET; Denkert C; Sehouli J; Kunze CA; Dietel M; Braicu I; Letsch A; Darb-Esfahani S Gynecol Oncol; 2016 Mar; 140(3):494-502. PubMed ID: 26721227 [TBL] [Abstract][Full Text] [Related]
23. Clinical significance of up-regulated lncRNA NEAT1 in prognosis of ovarian cancer. Chen ZJ; Zhang Z; Xie BB; Zhang HY Eur Rev Med Pharmacol Sci; 2016 Aug; 20(16):3373-7. PubMed ID: 27608895 [TBL] [Abstract][Full Text] [Related]
24. Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer. Zhao L; Ji G; Le X; Wang C; Xu L; Feng M; Zhang Y; Yang H; Xuan Y; Yang Y; Lei L; Yang Q; Lau WB; Lau B; Chen Y; Deng X; Yao S; Yi T; Zhao X; Wei Y; Zhou S Cancer Res; 2017 Mar; 77(6):1369-1382. PubMed ID: 28087599 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients. Meng X; Joosse SA; Müller V; Trillsch F; Milde-Langosch K; Mahner S; Geffken M; Pantel K; Schwarzenbach H Br J Cancer; 2015 Nov; 113(9):1358-66. PubMed ID: 26393886 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of abnormally expressed lncRNAs in ovarian carcinoma: a systematic review and meta-analysis. Luo P; Liu XF; Wang YC; Li ND; Liao SJ; Yu MX; Liang CZ; Tu JC Oncotarget; 2017 Apr; 8(14):23927-23936. PubMed ID: 28118613 [TBL] [Abstract][Full Text] [Related]
27. Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation. Yan L; Zhou J; Gao Y; Ghazal S; Lu L; Bellone S; Yang Y; Liu N; Zhao X; Santin AD; Taylor H; Huang Y Oncogene; 2015 Jun; 34(23):3076-84. PubMed ID: 25088204 [TBL] [Abstract][Full Text] [Related]
28. An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer. Li J; Liang S; Yu H; Zhang J; Ma D; Lu X Gynecol Oncol; 2010 Dec; 119(3):543-8. PubMed ID: 20869762 [TBL] [Abstract][Full Text] [Related]
29. Diminished miR-613 expression as a novel prognostic biomarker for human ovarian cancer. Zhang X; Zhang H Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):837-41. PubMed ID: 27010138 [TBL] [Abstract][Full Text] [Related]
30. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer. Shang C; Guo Y; Zhang J; Huang B Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384 [TBL] [Abstract][Full Text] [Related]
31. HOTAIR Interacting with MAPK1 Regulates Ovarian Cancer skov3 Cell Proliferation, Migration, and Invasion. Yiwei T; Hua H; Hui G; Mao M; Xiang L Med Sci Monit; 2015 Jun; 21():1856-63. PubMed ID: 26117268 [TBL] [Abstract][Full Text] [Related]
32. Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer. Zou J; Yin F; Wang Q; Zhang W; Li L Int J Clin Exp Pathol; 2015; 8(6):6847-58. PubMed ID: 26261572 [TBL] [Abstract][Full Text] [Related]
33. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression. Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143 [TBL] [Abstract][Full Text] [Related]
34. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma. Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603 [TBL] [Abstract][Full Text] [Related]
35. Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes. Tripathi MK; Doxtater K; Keramatnia F; Zacheaus C; Yallapu MM; Jaggi M; Chauhan SC Drug Discov Today; 2018 Sep; 23(9):1635-1643. PubMed ID: 29698834 [TBL] [Abstract][Full Text] [Related]
36. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis]. Li J; Liang SH; Lu X Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563 [TBL] [Abstract][Full Text] [Related]
37. Functions and Mechanisms of Long Noncoding RNAs in Ovarian Cancer. Ren C; Li X; Wang T; Wang G; Zhao C; Liang T; Zhu Y; Li M; Yang C; Zhao Y; Zhang GM Int J Gynecol Cancer; 2015 May; 25(4):566-9. PubMed ID: 25756403 [TBL] [Abstract][Full Text] [Related]
38. MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine (Review). Palma Flores C; García-Vázquez R; Gallardo Rincón D; Ruiz-García E; Astudillo de la Vega H; Marchat LA; Salinas Vera YM; López-Camarillo C Int J Oncol; 2017 May; 50(5):1461-1476. PubMed ID: 28393213 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
40. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell. Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]